Detalhe da pesquisa
1.
Safety of House Dust Mite Subcutaneous Immunotherapy with a rush and cluster combination protocol in the build-up phase.
Asian Pac J Allergy Immunol
; 2023 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061934